Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder (TD)

NCT01418352 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

Tourette's Disorder

Interventions

DRUG: Aripiprazole
DRUG: Placebo

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.